Search
Sign In
Sign In
Sources
5 Total Sources
AstraZeneca Halts 895-Patient Volrustomig Lung Cancer Phase III Trial After Futility Review
Left
100%
All
5
Left
1
Others
4
XTB
3d ago
AstraZeneca Halts Volrustomig Lung Cancer Trials Due to Ineffectiveness
AstraZeneca
3d ago
AstraZeneca Discontinues Volrustomig mNSCLC Phase III Trial
Oncodaily
3d ago
AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig Plus Chemotherapy in Metastatic NSCLC - OncoDaily
Bloomberg
3d ago
AstraZeneca Halts Volrustomig Lung Cancer Drug Trial Due to Lack of Efficacy
The National Tribune
3d ago
Update on eVOLVE-Lung02 Phase III trial of volrustomig plus chemotherapy in metastatic non-small cell lung cancer | The National Tribune